【摘 要】
：
Background and Aims: Chronic liver failure (CLIF)-SOFA score was introduced to the diagnostic criteria for acute-chronic liver failure (ACLF) in recent by the European Association for The Study of Liv
【机 构】
：
解放军302医院肝衰竭诊疗与研究中心
【出 处】
：
中华医学会第五次全国病毒性肝炎慢性化、重症化基础与临床研究进展学术会议
论文部分内容阅读
Background and Aims: Chronic liver failure (CLIF)-SOFA score was introduced to the diagnostic criteria for acute-chronic liver failure (ACLF) in recent by the European Association for The Study of Liver Diseases (EASL)-CLIF Consortium.
其他文献
Aims : The aim of this study is to evaluate its impact on clinical outcome and identify the potential risk factors for its development in these patients.Methods : In this retrospective and case contro
Background and aims : Nonalcoholic steatohepatitis (NASH) may progress to endstage liver disease and hepatocellular carcinoma.The epoxyeicosatrienoic acids (EETs), the products of cytochrome P450 epox
Aim : A lot of research shows hepatocyte apoptosis induced by TNF-α/TNFR1 or Fas/FasL and high expression of IFN-γ are important pathway for the incidence of fulminant viral hepatitis.
Aims: Natural killer (NK) cells play pivotal roles in the control and clearance of hepatitis B virus (HBV) in chronically infected patients.This study aimed to investigate the dynamic changes of NK ce
Background Mother-to-child transmission (MTCT) of hepatitis B virus (HBV) still remains a world concerned question.Previous studies have demonstrated the effectiveness of telbivudine (LdT) and lamivud
Backgrounds and aims: Sodium taurocholate cotransporting polypeptide (NTCP, encoded by SLC10A1), a multiple transmembrane transporter predominantly expressed in the liver, was found as a functional re
急性肾损伤概念的变迁·1796年Morgagni提出了"少尿"的概念·1900年古希腊医学家Galen发现了患者突然无尿的现象,称其为尿闭症(ischuria),并将其分为膀胱充盈型及膀胱空虚型,而后者被认为是对AKI最早的认识·"ARF"的概念于1951年首次正式提出·2002年以来提出了AKINatural history of cirrhosis
Background & Aims: The pattern of cytokines in sera was consistent with the level of inflammation during chronic hepatitis.By observing the difference of cytokines expression between HBeAg-positive an
目的:探讨恩替卡韦联合细胞因子诱导的杀伤细胞(CIK)治疗HBeAg阳性慢性乙型肝炎(CHB)的临床疗效及安全性.方法:收集50例HBeAg阳性CHB患者,其中治疗组20例,采用恩替卡韦联合CIK治疗,对照组30例,单用恩替卡韦治疗.观察所有患者治疗前及治疗后第12、24、48周肝功能、HBV血清标志物和HBV DNA水平并进行统计学分析,同时对不良反应进行评估.
目的:本研究探讨CTLA4+49G/A位点基因多态性与HBV感染慢性化及乙肝相关肝癌的相关性,并了解慢乙肝及肝癌患者Th1/Th2平衡状态.方法:应用基因测序方法对HBV相关肝癌患者154例,慢性乙型肝炎患者199例,HBV自限性感染患者232例的CTLA4基因+49G/A位点进行检测,分析此多态性与慢性乙型肝炎及乙肝相关HCC之间的关系;同时对患者外周血单个核细胞(PBMCs)经梯度密度离心法分